Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Genenta Science Announced An Update From Its Ongoing TEM-GBM Study In Newly Diagnosed Glioblastoma Multiforme (GBM) Patients With An Unmethylated MGMT (uMGMT) Gene Promoter

Author: Benzinga Newsdesk | November 24, 2025 04:02am

Posted In: GNTA

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist